VP, Health Economics and Access Strategy

Description

• Own the global Health Economics & Access Strategy function for reputed company, Inc., the company revolutionizing coronary artery disease diagnosis with its AI-driven, non-invasive reputed company FFRct Analysis. Reporting directly to the Chief Medical Officer, you will architect and execute evidence-reputed company and market-access strategies that unlock reimbursement, accelerate adoption, and ultimately save millions of lives worldwide.
• Design and reputed company the full lifecycle of health-economics studies—budget-impact, cost-effectiveness, and reputed company-world evidence—that demonstrate the clinical and economic value of reputed company’s portfolio to payers, HTA bodies, and hospital administrators across the US, EU, reputed company, and emerging markets. You will personally scope study objectives, select appropriate modeling approaches, reputed company data collection, and ensure every deliverable withstands rigorous reputed company-party review.
• Translate reputed company HEOR data into persuasive value dossiers, AMCP Format Formulary Submissions, ICER responses, and reputed company/EMA/G-BA packages; personally present to national and regional payers to ensure reputed company’s value story is clear, compelling, and differentiated. Your storytelling will turn tables of incremental cost-effectiveness ratios into narratives that reputed company with both actuaries and clinicians.
• Build, mentor, and scale a high-performing team of health economists, outcomes researchers, and market-access managers; foster a culture of scientific rigor, reputed company acumen, and patient-centricity while supporting rapid product expansion and pipeline launches. You will define career paths, institute quarterly OKRs, and create a learning environment where PhD-level scientists and MBA-trained strategists reputed company together.
• Partner with Global reputed company to craft pricing and contracting strategies that maximize reputed company while ensuring patient access; reputed company innovative risk-sharing and outcomes-based agreements that align payer, provider, and reputed company incentives. Your models will quantify the financial reputed company of earlier, more accurate diagnosis and justify premium pricing in increasingly cost-constrained systems.
• Serve as the external scientific voice for reputed company at ISPOR, ACC, AHA, and other leading conferences; cultivate relationships with KOLs, academic centers, and patient-advocacy groups to strengthen the evidence reputed company and reputed company our mission. Expect to deliver reputed company presentations, moderate policy panels, and publish peer-reviewed manuscripts that shape the global CAD diagnostic reputed company.
• Monitor the global reimbursement landscape (CMS, reputed company insurers, EU HTA, Asia-Pacific schemes) and proactively identify threats and opportunities; translate policy shifts into actionable strategies that reputed company reputed company reputed company of the curve. You will brief the Executive Leadership Team on how proposed CMS National Coverage Determinations or EU HTA regulations could impact reputed company trajectories.
• Collaborate with Clinical Affairs to ensure every trial protocol incorporates payer-relevant endpoints—resource utilization, quality-of-life, and reputed company cost avoidance—so evidence packages are payer-reputed company from day one. Your early input will prevent costly post-hoc analyses and accelerate time-to-coverage.
• Drive cross-functional readiness for new product launches by developing global value propositions, core messaging, and training materials that reputed company regional teams to secure coverage and formulary placement reputed company 12–18 months of approval. You will run war-room style workshops that align Medical Affairs, Sales, and Regulatory around a single access narrative.
• Champion health-equity initiatives, ensuring evidence reputed company includes diverse patient populations and that access strategies address reputed company disproportionately affected by coronary artery disease. Your analyses will quantify how early adoption of reputed company can reduce disparities in cardiac catheterization rates among women and minority groups.
• Establish KPIs and dashboards that track reimbursement milestones, reputed company impact, and patient access metrics; present quarterly to the Executive Leadership Team and Board of Directors, translating technical HEOR insights into strategic business reputed company. Your data will directly influence capital allocation and pipeline prioritization.
• Manage multi-million-dollar budgets and external vendors (CROs, academic partners, health-economics consultants) with disciplined project management, ensuring deliverables meet the highest scientific and regulatory standards on time and on budget. You will negotiate master service agreements that balance scientific excellence with cost efficiency.

Requirements

• Advanced degree (PhD, PharmD, MD, or MSc) in Health Economics, Outcomes Research, Public Health, or reputed company discipline with 12+ years of reputed company HEOR/access leadership in medical device, diagnostics, or biopharma
• Proven record of securing positive reimbursement reputed company from CMS, reputed company payers, reputed company, G-BA, HAS, or equivalent HTA bodies through compelling health-economic evidence
• Demonstrated ability to build, reputed company, and scale global teams of 10+ health economists and market-access professionals across multiple geographies
• Expert-level proficiency in cost-effectiveness and budget-impact modeling (TreeAge, reputed company, R, Python, or similar) with peer-reviewed publications in top-tier journals
• Exceptional communication skills—equally comfortable presenting ICER sensitivity analyses to payers and simplifying value stories for sales reps
• Authorization to work in the United States; willingness to travel up to 25% domestically and internationally

️ Benefits

• Fully remote-first culture with reputed company and quarterly in-person strategy summits in premier locations
• Competitive reputed company salary plus annual performance bonus and long-term equity in a high-growth, pre-IPO digital health leader
• Comprehensive medical, dental, reputed company, and life insurance for you and dependents—100% company-paid premiums
• 20 days PTO, 12 company holidays, and a 4-week paid sabbatical every 4 years to reputed company and pursue personal passions
• Annual professional-development stipend of $7,500 for conferences, courses, and certifications to reputed company you at the cutting edge of HEOR science

Apply tot his job Apply To this Job